NEWS
News Articles
FDA Approves First Treatment for COVID-19
Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization. Veklury should only be administered in a hospital or in a healthcare setting capable of…
Read MoreStudy finds biopharmaceutical innovation is responsible for 35% of the increase in life expectancy from 1990 to 2015
Medicines are responsible for more than a third of the improvement in life expectancy from 1990 to 2015, according to a recent study published in Health Affairs. This underscores the crucial role of biopharmaceutical innovation, as life expectancy increased 3.3 years during that time period. For all causes of death, public health interventions were accountable for 44%…
Read MoreLargent Health Announces the Commercial Availability of FiteBac Antimicrobial Cavity Cleanser
FiteBac® Antimicrobial Cavity Cleanser represents the 1st antimicrobial dental cavity cleanser cleared by FDA. Largent Health, LLC announced today the U.S. commercial availability of FiteBac® Antimicrobial Cavity Cleanser, with 2% K21. Dental cavity cleansers are used for cleansing and moistening/re-wetting of prepared dental surfaces prior to completion of tooth restoration. The company included in their…
Read MoreCOVID-19 mRNA vaccine candidate from Sanofi and Translate protects mice, monkeys: study
Moderna and Pfizer may be considered the front-runners in the effort to develop mRNA vaccines against COVID-19, but they’re not the only contenders in that race. Sanofi and its partner Translate Bio have also been working on a vaccine that uses mRNA to prompt an immune response—and now they have animal data that they believe…
Read MoreNCI awarding Emory $9.9 million to study cancer, autoimmune intersection with COVID-19
The National Cancer Institute has awarded a five-year, $9.9 million grant to Emory investigators to study COVID-19 immune responses in patients with cancer or autoimmune diseases. “This is a highly collaborative effort to study the unique challenges facing people with cancers and autoimmune disorders when dealing with COVID-19,” says Madhav Dhodapkar, MBBS, director of the…
Read MoreFDA Approves First Treatment for Ebola Virus
Today, the U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved treatment for Zaire ebolavirus (Ebola virus) infection in adult and pediatric patients. “Today’s action demonstrates the FDA’s ongoing commitment to responding to public health threats—both domestically and abroad—on the basis of science and data,”…
Read More